981 related articles for article (PubMed ID: 19780195)
1. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Berard JL; Wolak K; Fournier S; David S
Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
[TBL] [Abstract][Full Text] [Related]
2. T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice.
Zhang GX; Yu S; Gran B; Li J; Calida D; Ventura E; Chen X; Rostami A
J Neuroimmunol; 2004 Mar; 148(1-2):1-10. PubMed ID: 14975581
[TBL] [Abstract][Full Text] [Related]
3. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
Papadopoulos D; Pham-Dinh D; Reynolds R
Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
[TBL] [Abstract][Full Text] [Related]
4. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
5. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
6. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
7. Pathological findings in rats with experimental allergic encephalomyelitis.
Dong M; Liu R; Guo L; Li C; Tan G
APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
[TBL] [Abstract][Full Text] [Related]
8. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
9. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity.
Berard JL; Kerr BJ; Johnson HM; David S
Glia; 2010 Nov; 58(15):1816-26. PubMed ID: 20645407
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
[TBL] [Abstract][Full Text] [Related]
12. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.
Furlan R; Martino G; Galbiati F; Poliani PL; Smiroldo S; Bergami A; Desina G; Comi G; Flavell R; Su MS; Adorini L
J Immunol; 1999 Sep; 163(5):2403-9. PubMed ID: 10452974
[TBL] [Abstract][Full Text] [Related]
13. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Black JA; Liu S; Hains BC; Saab CY; Waxman SG
Brain; 2006 Dec; 129(Pt 12):3196-208. PubMed ID: 16931536
[TBL] [Abstract][Full Text] [Related]
14. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
15. Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation.
Tsunoda I; Kuang LQ; Igenge IZ; Fujinami RS
J Neuroimmunol; 2005 Mar; 160(1-2):122-34. PubMed ID: 15710465
[TBL] [Abstract][Full Text] [Related]
16. EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses.
Linker RA; Rott E; Hofstetter HH; Hanke T; Toyka KV; Gold R
Neurobiol Dis; 2005; 19(1-2):218-28. PubMed ID: 15837577
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis.
Hiraki K; Park IK; Kohyama K; Matsumoto Y
J Neurosci Res; 2009 Apr; 87(5):1175-84. PubMed ID: 18951531
[TBL] [Abstract][Full Text] [Related]
18. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.
Park IK; Hiraki K; Kohyama K; Matsumoto Y
J Neuroimmunol; 2008 Feb; 194(1-2):34-43. PubMed ID: 18155779
[TBL] [Abstract][Full Text] [Related]
20. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]